Lokesh Guglani

Lokesh Guglani

Auto-generated profile, based on publicly available information

Lokesh Guglani

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Immunity
Verified
Journal Article
Closed access
YLYinyao Lin
Yinyao Lin
SRShane Ritchea
Shane Ritchea
ALAlison Logar
Alison Logar
SSSamantha Slight
Samantha Slight
MMMichelle Messmer
Michelle Messmer
SKShabaana A. Khader
Shabaana A. Khader

15 November 2011 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SKShabaana A Khader
Shabaana A Khader
LGLokesh Guglani
Lokesh Guglani
RJRangel Moreno Javier
Rangel Moreno Javier
RGRadha Gopal
Radha Gopal
BJBeth A. Fallert Junecko
Beth A. Fallert Junecko
ACAndrea Cooper
Andrea Cooper
IL-23 is required for the IL-17 response to infection with Mycobacterium tuberculosis, but is not required for the early control of bacterial growth. However, mice deficient for the p19 component of IL-23 (Il23a−/−) exhibit increased bacterial growth late in infection that is temporally associated with smaller B cell follicles in the lungs. Cxcl13 is required for B cell follicle formation and immunity during tuberculosis. The absence of IL-23 results in decreased expression of Cxcl13 within M. tuberculosis-induced lymphocyte follicles in the lungs, and this deficiency was associated with increased cuffing of T cells around the vessels in the lungs of these mice. Il23a−/− mice also poorly expressed IL-17A and IL-22 mRNA. These cytokines were able to induce Cxcl13 in mouse primary lung fibroblasts, suggesting that these cytokines are likely involved in B cell follicle formation. Indeed, IL-17RA–deficient mice generated smaller B cell follicles early in the response, whereas IL-22–deficient mice had smaller B cell follicles at an intermediate time postinfection; however, only Il23a−/− mice had a sustained deficiency in B cell follicle formation and reduced immunity. We propose that in the absence of IL-23, expression of long-term immunity to tuberculosis is compromised due to reduced expression of Cxcl13 in B cell follicles and reduced ability of T cells to migrate from the vessels and into the lesion. Further, although IL-17 and IL-22 can both contribute to Cxcl13 production and B cell follicle formation, it is IL-23 that is critical in this regard.

1 March 2010 in Current Opinion in HIV and AIDS
Verified
Journal Article
Closed access
LGLokesh Guglani
Lokesh Guglani
SKShabaana A Khader
Shabaana A Khader
Purpose of review Compelling evidence suggests that the Th17 lineage and other IL-17-producing cells play critical roles in host defense against pathogens at mucosal sites. However, IL-17 can also contribute to inflammatory responses at mucosal sites. In this review, we will discuss the recent progress in our understanding of the role of Th17 and other IL-17-producing cells in defining the fine balance between immunity and inflammation at different mucosal sites. Recent fndings Recent findings have highlighted that Th17 cytokines are important for the induction of innate and adaptive host responses and contribute to host defense against pathogens at mucosal sites. More recent developments have probed how the Th17 responses are generated in vivo in response to infections and their requirement in maintaining barrier function at mucosal sites. Most importantly, it is becoming apparent that there is a fine balance between protective and pathological manifestation of Th17 responses at mucosal sites that defines immunity or inflammation. Summary In this review, we have summarized the recent advances in our understanding of Th17 cytokines and how they contribute to immunity versus inflammation at mucosal sites.

1 April 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
CMCamilla Margaroli
Camilla Margaroli
LGLuke Garratt
Luke Garratt
HHHamed Horati
Hamed Horati
ADA. Susanne Dittrich
A. Susanne Dittrich
TRTimothy Rosenow
Timothy Rosenow
RTRabindra Tirouvanziam
Rabindra Tirouvanziam
Rationale: Neutrophils are recruited to the airways of individuals with cystic fibrosis (CF). In adolescents and adults with CF, airway neutrophils actively exocytose the primary granule protease elastase (NE), whose extracellular activity correlates with lung damage. During childhood, free extracellular NE activity is measurable only in a subset of patients, and the exocytic function of airway neutrophils is unknown. Objectives: To measure NE exocytosis by airway neutrophils in relation to free extracellular NE activity and lung damage in children with CF. Methods: We measured lung damage using chest computed tomography coupled with the Perth-Rotterdam Annotated Grid Morphometric Analysis for Cystic Fibrosis scoring system. Concomitantly, we phenotyped blood and BAL fluid leukocytes by flow and image cytometry, and measured free extracellular NE activity using spectrophotometric and Förster resonance energy transfer assays. Children with airway inflammation linked to aerodigestive disorder were enrolled as control subjects. Measurements and Main Results: Children with CF but not disease control children harbored BAL fluid neutrophils with high exocytosis of primary granules, before the detection of bronchiectasis. This measure of NE exocytosis correlated with lung damage (R = 0.55; P = 0.0008), whereas the molecular measure of free extracellular NE activity did not. This discrepancy may be caused by the inhibition of extracellular NE by BAL fluid antiproteases and its binding to leukocytes. Conclusions: NE exocytosis by airway neutrophils occurs in all children with CF, and its cellular measure correlates with early lung damage. These findings implicate live airway neutrophils in early CF pathogenesis, which should instruct biomarker development and antiinflammatory therapy in children with CF.

20 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LGLokesh Guglani
Lokesh Guglani
RGRadha Gopal
Radha Gopal
RJRangel Moreno Javier
Rangel Moreno Javier
BJBeth Fallert Junecko
Beth Fallert Junecko
YLYinyao Lin
Yinyao Lin
SKShabaana A. Khader
Shabaana A. Khader
Pulmonary tuberculosis (TB), caused by the intracellular bacteria Mycobacterium tuberculosis, is a worldwide disease that continues to kill more than 1.5 million people every year worldwide. The accumulation of lymphocytes mediates the formation of the tubercle granuloma in the lung and is crucial for host protection against M.tuberculosis infection. However, paradoxically the tubercle granuloma is also the basis for the immunopathology associated with the disease and very little is known about the regulatory mechanisms that constrain the inflammation associated with the granulomas. Lipocalin 2 (Lcn2) is a member of the lipocalin family of proteins and binds to bacterial siderophores thereby sequestering iron required for bacterial growth. Thus far, it is not known whether Lcn2 plays a role in the inflammatory response to mycobacterial pulmonary infections. In the present study, using models of acute and chronic mycobacterial pulmonary infections, we reveal a novel role for Lcn2 in constraining T cell lymphocytic accumulation and inflammation by inhibiting inflammatory chemokines, such as CXCL9. In contrast, Lcn2 promotes neutrophil recruitment during mycobacterial pulmonary infection, by inducing G-CSF and KC in alveolar macrophages. Importantly, despite a common role for Lcn2 in regulating chemokines during mycobacterial pulmonary infections, Lcn2 deficient mice are more susceptible to acute M.bovis BCG, but not low dose M.tuberculosis pulmonary infection.

31 October 2008 in Pediatrics in Review
Verified
Journal Article
Closed access
PDF file
LGLokesh Guglani
Lokesh Guglani
SLSatyan Lakshminrusimha
Satyan Lakshminrusimha
Rita Marie RyanRita Marie Ryan
Rita Marie Ryan